Statutory board seatOpen Open to a non-residentGIDX-FR-0195

Nonexecutive Director for Restructuring and Recovery Oversight

France·Funds & Asset Management·Private equity portfolio companies undergoing recovery· Paris·Posted 25 September 2026

Applications close 18 November 2026

Private equity portfolio companies undergoing recovery

Partner-sourced

Sourced through a partner search firm or the sponsor's own nomination committee, and verified before listing.

The problem this seat exists to solve

A portfolio company needs independent challenge of an ambitious recovery plan and clearer visibility of execution risk. The director will strengthen board scrutiny of liquidity, management capacity and strategic options while preserving management ownership of the turnaround.

Board mandate

This is a nonexecutive appointment. The director contributes through the chair to collective board decisions and oversight; management retains responsibility for execution.

The scrutiny expected of you

  • Challenge cash forecasts, downside scenarios and the assumptions underpinning the recovery investment case.
  • Review whether management capacity and incentives support the proposed change programme.
  • Scrutinise refinancing, disposals and new capital proposals for execution risk and implications for the business.
  • Ensure the board receives evidence of realised benefits and early warning signals rather than optimistic progress narratives.
  • Support orderly CEO or CRO succession and maintain constructive challenge between the sponsor and executive team.

First two meetings

First two board meetings: agree a recovery dashboard and identify the highest-risk assumptions needing independent validation.

Six and twelve month reviews

Within six months: complete a structured review of strategic options and the credibility of the operating recovery. Within twelve months: assess realised performance, leadership capability and remaining risks against the board-approved plan.

Suitability for the seat

The role requires substantial executive restructuring experience, strong financial judgement and the ability to operate within collective board decision making.

Additional useful experience includes previous nonexecutive service and experience navigating sponsor, lender and minority investor interests.

Time commitment

An initial three-year appointment is envisaged, with approximately eighteen to twenty-four days annually for meetings, preparation and committee work. Start date, remuneration, travel and on-site attendance will be agreed for the appointment.

Terms

Where the board sits
Paris, France
Applications close
18 November 2026
Appointment
Board appointment
Engagement
An initial three-year appointment is envisaged, with approximately eighteen to twenty-four days annually for meetings, preparation and committee work.
Cross-border
International candidatures are accepted.
Time commitment in this market
Typically 6–10 board meetings a year plus committee cycles and a strategy seminar; audit committees at CAC 40 issuers meet considerably more often.

Before you apply — France

No nationality or residency test applies to a director of a French société anonyme. The constraint on a French board is its composition arithmetic, not your passport.

Residency test
None.
Nationality test
None.
Work authorisation
A non-executive director attending board meetings requires no work authorisation. An executive mandate — directeur général or a directoire seat — held by a non-EU national raises residence-permit questions and should be checked before acceptance.
Tenure limit once appointed
Twelve years. Under the AFEP-MEDEF Code a director loses independent status on passing twelve years' service, and the board must state the position each year.
The full France regime map

Global ID Exchange

One account. Every market your record travels to.

A free account applies to one mandate a week, in any market — statutory, interim or advisory — and your dashboard reads every brief that opens in the exchanges you follow. Premium removes the weekly cap.